help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olson, D.
Right arrow Articles by Hall, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olson, D.
Right arrow Articles by Hall, J. B.

Am. J. Respir. Crit. Care Med., Vol 154, No. 6, Dec 1996, 1664-1670.

Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH nor improve creatinine clearance

D Olson, A Pohlman and JB Hall
Section of Pulmonary and Critical Care Medicine, University of Chicago Hospitals and Clinics, Illinois, USA.

Tissue hypoxia resulting from regional blood flow abnormalities and oxygen extraction defects may underlie the pathogenesis of multiple system organ failure (MSOF) in sepsis. Low-dose dopamine (LDD) is widely employed to enhance splanchnic perfusion although data to support this approach are lacking. We assessed the effect of LDD on surrogate markers of renal and gastric perfusion. Sixteen nonoliguric mechanically ventilated patients with sepsis syndrome received LDD (3 micrograms/kg/min) or placebo in a double-blind crossover design experiment. Hemodynamics, gastric intramucosal pH (pHi) urine volumes, urinary sodium excretion, and cimetidine-corrected creatinine clearance were compared. Mortality for the group was 63%. LDD caused a significant increase in urine volume (88 +/- 58 to 115 +/- 70 ml/h, p = 0.02, 95% confidence interval for change 4.7 to 49 ml/h), but no significant change in any other parameter. We conclude that use of LDD results in diuresis but does not improve other markers of renal or gut perfusion. These data do not support the use of LDD to reduce risk of progression to MSOF in sepsis.


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
J. O. Friedrich, N. Adhikari, M. S. Herridge, and J. Beyene
Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death
Ann Intern Med, April 5, 2005; 142(7): 510 - 524.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. A. Debaveye and G. H. Van den Berghe
Is There Still a Place for Dopamine in the Modern Intensive Care Unit?
Anesth. Analg., February 1, 2004; 98(2): 461 - 468.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. L. Holmes and K. R. Walley
Bad Medicine: Low-Dose Dopamine in the ICU
Chest, April 1, 2003; 123(4): 1266 - 1275.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. A. Guzman, A. E. Rosado, and J. A. Kruse
Dopamine-1 receptor stimulation attenuates the vasoconstrictive response to gut ischemia
J Appl Physiol, August 1, 2001; 91(2): 596 - 602.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1996 American Thoracic Society